Essential tremor-plus: a controversial new concept.

Consensus Essential Tremor / diagnosis Humans Tremor / diagnosis

Journal

The Lancet. Neurology
ISSN: 1474-4465
Titre abrégé: Lancet Neurol
Pays: England
ID NLM: 101139309

Informations de publication

Date de publication:
03 2020
Historique:
received: 29 04 2019
revised: 18 07 2019
accepted: 01 08 2019
pubmed: 27 11 2019
medline: 16 7 2020
entrez: 27 11 2019
Statut: ppublish

Résumé

In addition to redefining essential tremor (ET), the 2018 consensus statement of the Movement Disorder Society on tremor coined a new term: essential tremor-plus (ET-plus). This term is uncertainly defined as tremor with the characteristics of ET, with additional neurological signs of uncertain clinical significance. If ET-plus had been defined on the basis of a difference in underlying pathology or an appreciable difference in prognosis, it would have a valid, scientific rationale, as does the term Parkinson-plus. However, there is no such evidence, so the basis for the term is questionable. In fact, ET-plus might only represent a state condition (ie, patients with ET might develop these additional clinical features when the disease is at a more advanced stage). We caution against coining new terms that are not supported by a firm scientific basis and encourage research into the creation of essential tremor subsets that are defined with respect to differences in underlying causes or pathophysiology.

Identifiants

DOI: 10.1016/S1474-4422(19)30398-9 PMID: 31767343 PMC: PMC10686582
pubmed: 31767343
pii: S1474-4422(19)30398-9
doi: 10.1016/S1474-4422(19)30398-9
pmc: PMC10686582
mid: NIHMS1913124
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

266-270

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS073872
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS085136
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS088257
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS094607
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

J Am Med Dir Assoc. 2009 May;10(4):218-20
pubmed: 19426934
Parkinsonism Relat Disord. 2018 Nov;56:111-112
pubmed: 29937098
J Clin Neurosci. 2014 Jun;21(6):1002-6
pubmed: 24602359
Neurology. 2009 Aug 25;73(8):621-5
pubmed: 19704081
J Neurol Neurosurg Psychiatry. 2009 Apr;80(4):423-5
pubmed: 19289477
Mov Disord. 2016 Mar;31(3):393-401
pubmed: 26861543
Mov Disord. 2004 Feb;19(2):217-20
pubmed: 14978680
Mov Disord. 2010 Aug 15;25(11):1633-8
pubmed: 20629168
Mov Disord. 2019 Mar;34(3):437
pubmed: 30653249
Mov Disord. 2014 Nov;29(13):1637-47
pubmed: 24531928
J Alzheimers Dis. 2011;23(4):727-35
pubmed: 21304183
Mov Disord. 2012 Dec;27(14):1741-2
pubmed: 23283653
Eur J Neurol. 2013 Jun;20(6):949-54
pubmed: 23521518
Can J Neurol Sci. 2015 May;42(3):181-6
pubmed: 25857448
J Neurol Neurosurg Psychiatry. 2006 Nov;77(11):1235-7
pubmed: 17043291
Brain. 2007 Dec;130(Pt 12):3297-307
pubmed: 18025031
Arch Phys Med Rehabil. 2006 Oct;87(10):1357-64
pubmed: 17023246
Neuroepidemiology. 2008;31(3):191-2
pubmed: 18784419
Can J Neurol Sci. 2016 May;43(3):443-4
pubmed: 26738599
Mov Disord. 2002 Jul;17(4):633-7
pubmed: 12210850
JAMA Neurol. 2016 Jul 1;73(7):888-90
pubmed: 27182963
Cerebellum. 2017 Apr;16(2):577-594
pubmed: 27734238
Neurosurgery. 2014 Dec;75(6):657-69; discussion 669-70
pubmed: 25161000
Brain. 2013 Oct;136(Pt 10):3051-61
pubmed: 24030953
Parkinsonism Relat Disord. 2018 Nov;56:109-110
pubmed: 29958776
J Neurol Sci. 2013 Dec 15;335(1-2):9-13
pubmed: 24060292
Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S87-S91
pubmed: 28747280
Brain. 2014 Dec;137(Pt 12):3142-8
pubmed: 25367027
Mov Disord. 2019 Jul;34(7):975-984
pubmed: 31034671
Mov Disord. 2018 Jan;33(1):3-4
pubmed: 29193400
Acta Neurol Belg. 2015 Sep;115(3):281-7
pubmed: 25471376
Mov Disord. 2006 Nov;21(11):1872-8
pubmed: 16941462
Mov Disord. 2007 Aug 15;22(11):1573-80
pubmed: 17516478
Brain. 2012 Jan;135(Pt 1):105-16
pubmed: 22120148
Mov Disord. 2009 Mar 15;24(4):626-7
pubmed: 19185016
Mov Disord. 2018 Oct;33(10):1601-1608
pubmed: 30145797
Eur J Neurol. 2012 Apr;19(4):625-30
pubmed: 22136494
Mov Disord. 2010 Apr 15;25(5):534-41
pubmed: 20175185
Brain. 2018 Jun 1;141(6):1770-1781
pubmed: 29701820
Mov Disord. 2002 Jul;17(4):638-44
pubmed: 12210851
Brain. 2015 Oct;138(Pt 10):2934-47
pubmed: 26248468
Cerebellum. 2016 Jun;15(3):235-42
pubmed: 26129713
Mov Disord. 1998;13 Suppl 3:2-23
pubmed: 9827589
Neurology. 2008 Apr 15;70(16 Pt 2):1452-5
pubmed: 18413570
J Neurol Neurosurg Psychiatry. 2018 May;89(5):488-492
pubmed: 29089396
Cerebellum. 2018 Apr;17(2):104-110
pubmed: 28791574
Pract Neurol. 2019 Oct;19(5):389-398
pubmed: 31273079
Tremor Other Hyperkinet Mov (N Y). 2019 Jan 9;8:589
pubmed: 30643667
Brain. 2014 Dec;137(Pt 12):3149-59
pubmed: 25273997
Mov Disord. 2018 Jan;33(1):75-87
pubmed: 29193359
Mov Disord. 2009 Nov 15;24(15):2272-6
pubmed: 19845011
Mov Disord. 2019 Mar;34(3):317-320
pubmed: 30726575
Curr Neurol Neurosci Rep. 2013 Sep;13(9):378
pubmed: 23893097
J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):761-5
pubmed: 21436230
J Neurodegener Dis. 2014;2014:328765
pubmed: 26317006
J Neurol Sci. 2015 Oct 15;357(1-2):304-6
pubmed: 26189053
Curr Neuropharmacol. 2013 Jan;11(1):30-40
pubmed: 23814535
Eur J Neurol. 2015 Jun;22(6):927-32
pubmed: 25786561
Mov Disord. 2013 Jun 15;28(7):863-73
pubmed: 23649720
Mov Disord. 2018 Jan;33(1):58-61
pubmed: 29272067
Brain. 2001 Nov;124(Pt 11):2278-86
pubmed: 11673328

Auteurs

Elan D Louis (ED)

Department of Neurology and Center for Neuroepidemiology and Clinical Neurological Research, Yale School of Medicine, Yale University, New Haven, CT, USA; Department of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT, USA. Electronic address: elan.louis@yale.edu.

Martin Bares (M)

1st Department of Neurology, St Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Neurology, University of Minnesota, Minneapolis, MN, USA.

Julian Benito-Leon (J)

Department of Neurology, University Hospital 12 de Octubre, Madrid, Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain; Department of Medicine, Complutense University, Madrid, Spain.

Stanley Fahn (S)

Movement Disorders Division, Department of Neurology, Columbia University, New York, NY, USA.

Steven J Frucht (SJ)

Marlene and Paolo Fresco Institute for Parkinson's Disease and Movement Disorders, New York University Langone Health, New York, NY, USA.

Joseph Jankovic (J)

Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA.

William G Ondo (WG)

Department of Neurology, Methodist Neurological Institute Houston, TX, USA; Weill Cornell Medical School, New York, NY, USA.

Pramod K Pal (PK)

National Institute of Mental Health and Neurosciences, Bangalore, India.

Eng-King Tan (EK)

National Neuroscience Institute, Singapore, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Essential tremor-plus: a controversial new concept.
questionsmedicales.fr › Maladies du système nerveux › Maladies du système nerveux central › Troubles de la motricité › Tremblement essentiel › Essential tremor-plus: a controversial new concept.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Essential tremor-plus: a controversial new concept.
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations neurologiques › Dyskinésies › Tremblement › Essential tremor-plus: a controversial new concept.